Gentamicin and Fexofenadine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gentamicin (gentamicin sulfate) and Fexofenadine hydrochloride (fexofenadine hydrochloride). Common drug interactions include arthralgia among females and hypoxia among males.

The phase IV clinical study analyzes what interactions people have when they take Gentamicin and Fexofenadine hydrochloride. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

What is Fexofenadine hydrochloride?

Fexofenadine hydrochloride has active ingredients of fexofenadine hydrochloride. It is often used in allergies. eHealthMe is studying from 6,908 Fexofenadine hydrochloride users. Check the latest studies of Fexofenadine hydrochloride.



On Jul, 12, 2026

45 people who take Gentamicin and Fexofenadine hydrochloride together, and have interactions are studied.

Gentamicin and Fexofenadine hydrochloride drug interactions.

What are the common drug interactions of Gentamicin and Fexofenadine Hydrochloride, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Bone pain
  3. C-reactive protein increased
  4. Cancer pain
  5. Diarrhoea
  6. Mucosal inflammation (infection of mucous membrane)
  7. Oedema peripheral (superficial swelling)
  8. Vomiting
  9. Wound
  10. Pain in extremity

male:

  1. Hypoxia (low oxygen in tissues)
  2. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  3. Rhinorrhoea (watery mucus discharge from the nose)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Skin infection
  6. Acquired hydrocele (collection of fluid in testis)
  7. C-reactive protein increased
  8. Catheter site infection (infection at the site of insertion)
  9. Cellulitis (infection under the skin)
  10. Chronic kidney disease

What are the common drug interactions of Gentamicin and Fexofenadine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Respiratory disorder (respiratory disease)

20-29:

  1. Blood bilirubin increased
  2. Brain natriuretic peptide increased
  3. Decreased appetite
  4. Device related infection
  5. Hyperbilirubinaemia (excess of bilirubin in the blood)
  6. Hyperthyroidism (over activity of the thyroid gland)
  7. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  8. Nausea (feeling of having an urge to vomit)
  9. Pain in extremity
  10. Platelet count decreased

30-39:

  1. Constipation
  2. Pulseless electrical activity
  3. Pyrexia (fever)
  4. Sinus arrest (sinus pause)

40-49:

  1. Pericarditis (inflammation of the pericardium)

50-59:

  1. Renal transplant
  2. Rhinorrhoea (watery mucus discharge from the nose)
  3. Ventricular fibrillation (abnormally irregular heart rhythm)
  4. Catheter site infection (infection at the site of insertion)
  5. Chronic kidney disease
  6. Insomnia (sleeplessness)
  7. Rash
  8. Skin cancer

60+:

  1. Arthralgia (joint pain)
  2. C-reactive protein increased
  3. Hypoxia (low oxygen in tissues)
  4. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  5. Pneumonia influenzal (the flu with pneumonia)
  6. Fall
  7. Arthropathy
  8. Back pain
  9. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 9 people, 20.00%
  2. Hepatocellular Carcinoma (liver cancer): 6 people, 13.33%
  3. Itching: 6 people, 13.33%
  4. Multiple Myeloma (cancer of the plasma cells): 5 people, 11.11%
  5. Adverse Event: 4 people, 8.89%
  6. Breast Cancer: 4 people, 8.89%
  7. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 4 people, 8.89%
  8. Constipation: 4 people, 8.89%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 8.89%
  10. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 4 people, 8.89%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin and Fexofenadine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gentamicin and Fexofenadine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fexofenadine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gentamicin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fexofenadine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate and fexofenadine hydrochloride (the active ingredients of Gentamicin and Fexofenadine hydrochloride, respectively), and Gentamicin and Fexofenadine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: